Brief: Aptose Biosciences Announces Arrangement Agreement For Acquisition By Hanmi Pharmaceutical
19/11/2025 06:23
Nov 19 (Reuters) - Aptose Biosciences Inc APS.TO: APTOSE BIOSCIENCES ANNOUNCES ARRANGEMENT AGREEMENT FOR ACQUISITION BY HANMI PHARMACEUTICAL APTOSE BIOSCIENCES INC - SHAREHOLDERS TO RECEIVE C$2.41 PER SHARE, 28% PREMIUM APTOSE BIOSCIENCES INC - HANMI PURCHASER TO BUY ALL OUTSTANDING APTOSE SHARES Source text: ID:nGNXT2Kxp Further company coverage: APS.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting